XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Cash flows from operating activities:    
Net income $ 190,152 $ 145,608
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Equity in income of unconsolidated joint ventures (26,855) (5,859)
Distributions of earnings from unconsolidated joint ventures 29,384 6,450
Amortization of discounts, premiums and issuance costs 1,862 3,500
Depreciation and amortization 21,583 19,825
Deferred income taxes 40,200 35,701
Stock-based compensation 12,767 14,479
Inventory impairments and land option contract abandonments 16,939 13,143
Changes in assets and liabilities:    
Receivables 62,839 2,788
Inventories 46,567 (389,461)
Accounts payable, accrued expenses and other liabilities (62,419) 4,965
Other, net (3,808) (3,283)
Net cash provided by (used in) operating activities 329,211 (152,144)
Cash flows from investing activities:    
Contributions to unconsolidated joint ventures (6,048) (7,656)
Return of investments in unconsolidated joint ventures 8,816 5,001
Proceeds from sale of building 0 5,804
Purchases of property and equipment, net (21,154) (32,211)
Net cash used in investing activities (18,386) (29,062)
Cash flows from financing activities:    
Proceeds from issuance of debt 0 405,250
Issuance costs for unsecured revolving credit facility 0 (5,209)
Repayment of senior notes 0 (630,000)
Borrowings under revolving credit facility 0 460,000
Repayments under revolving credit facility 0 (410,000)
Payments on mortgages and land contracts due to land sellers and other loans (20,314) (32,149)
Issuance of common stock under employee stock plans 8,404 18,729
Tax payments associated with stock-based compensation awards (6,219) (3,345)
Payments of cash dividends (24,428) (12,352)
Net cash used in financing activities (42,557) (209,076)
Net increase (decrease) in cash and cash equivalents 268,268 (390,282)
Cash and cash equivalents at beginning of period 454,858 575,119
Cash and cash equivalents at end of period $ 723,126 $ 184,837